INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Regeneron Pharmaceuticals
Back to Newsroom
🏢Organization Dossier

Regeneron Pharmaceuticals

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

7 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Global Markets & Equities Just now (07:03 PM IST)

Sanofi Pays Regeneron $1 Billion Upfront to Deepen Drug Alliance and Reignite R&D

Sanofi has agreed to pay Regeneron $1 billion upfront in a broadened collaboration that could be worth as much as $8 billion, extending one of the biopharma sector’s most productive partnerships. The deal gives Sanofi access to four early-stage assets and comes alongside a legal settlement, underscoring both the commercial value of the alliance and the strategic urgency to refresh each company’s pipeline.

By RDU Global Wire6 min read
Clean Energy & Climate Transition22 Oct 2026, 08:00 AM IST

Nature Study Shows De Novo Artificial Metalloenzymes Can Be Tailored for Enantioselective Photocatalysis

A new Nature study reports a de novo design strategy for artificial metalloenzyme photocatalysts capable of steering reactions toward a preferred enantiomer, a long-sought goal in selective chemistry. The work strengthens the case for protein-engineered catalysts as a platform for cleaner, more precise chemical manufacturing with potential relevance to pharmaceuticals and low-waste industrial synthesis.

5 min readRead →
Clean Energy & Climate Transition16 Oct 2026, 11:32 AM IST

Single-Atom Carbon Transfer Opens New Route to 3D Molecular Architectures

Scientists have reported a catalytic method that transfers a single carbon atom to fuse flat molecules into rigid three-dimensional spirocyclic structures, a development that could reshape how complex organic compounds are built. The advance, published in Nature, points to a more direct way to construct high-value molecular frameworks relevant to pharmaceuticals, materials science, and potentially cleaner chemical manufacturing.

5 min readRead →
Clean Energy & Climate Transition16 Oct 2026, 12:15 AM IST

Single-Carbon Catalysis Opens a New Route to 3D Molecular Architectures

Scientists have reported a catalytic method that transfers a single carbon atom to fuse flat molecules into rigid three-dimensional spirocycles, a structural advance that could reshape how complex chemicals are built. The work, published in Nature, points to a more direct way to assemble high-value molecular frameworks relevant to pharmaceuticals, materials science, and potentially cleaner chemical manufacturing.

5 min readRead →
Macro Economy & Fiscal PolicyJust now (11:12 AM IST)

India’s factory growth hits 7-month high as demand surges, PMI shows

India’s manufacturing sector expanded at its fastest pace in seven months in August, powered by a sharp rise in new orders and stronger demand across electronics, food, pharmaceuticals and textiles, according to the latest purchasing managers’ survey. The reading points to resilient domestic and export demand, even as firms continued to face cost pressures and a softer pace of output growth than the surge in orders might suggest.

5 min readRead →
Clean Energy & Climate TransitionJust now (05:52 AM IST)

Nature Study Opens New Route for Cyclopropane Synthesis Using Thianthrenium Ylides

A new Nature study reports a carbene-transfer strategy built around thianthrenium ylides that enables cyclopropanation, a reaction central to making high-value molecular building blocks. The advance could broaden access to strained ring systems used across pharmaceuticals, agrochemicals and advanced materials, while offering chemists a more versatile synthetic toolset.

5 min readRead →
Macro Economy & Fiscal PolicyJust now (05:10 AM IST)

India’s factory growth hits 7-month high as demand surges, PMI shows

India’s manufacturing sector accelerated to a seven-month high in the latest purchasing managers’ survey, signalling that domestic demand remains resilient despite a challenging global backdrop. New orders expanded at the fastest pace since February, with electronics, food, pharmaceuticals and textiles among the key product categories driving the upturn.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Regeneron Pharmaceuticals: